Immediate Impact
52 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Hepatocellular carcinoma: signaling pathways and therapeutic advances
2025 Standout
Works of Lifeng Li being referenced
Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients
2021 Standout
Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinoma
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Lifeng Li | 122 | 132 | 167 | 26 | 438 | |
| Haipeng Huang | 138 | 112 | 130 | 29 | 508 | |
| Xudong Shen | 116 | 81 | 136 | 39 | 471 | |
| L.N. Daniel | 130 | 63 | 125 | 19 | 503 | |
| Ting‐Yu Chang | 67 | 45 | 179 | 22 | 463 | |
| Peiyong Li | 68 | 157 | 37 | 35 | 480 | |
| Eric Olsen | 50 | 87 | 77 | 39 | 511 | |
| Prabin D. Majhi | 66 | 160 | 71 | 14 | 497 | |
| Danni Li | 81 | 125 | 62 | 49 | 462 | |
| Zhiwei Yu | 76 | 132 | 140 | 25 | 471 | |
| Shutong Wang | 106 | 133 | 81 | 20 | 450 |
All Works
Login with ORCID to disown or claim papers
Loading papers...